All sponsors

GlaxoSmithKline $GSK

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS121
PHASE 3 / 2-365
RECRUITING72
READOUTS ≤12 MONTHS31
READOUT SLIPPED >6 MO37%

Delay Index: of 76 active trials registered more than a year ago, 28 have moved their primary completion (readout) date by more than 6 months since first registration (median +1.0 months). See all sponsors →

Open GlaxoSmithKline on the live radar map → 📅 $GSK readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
RSVPreF3 OA investigational vaccine
NCT04732871
P3Active, not recruitingRespiratory Syncytial Virus Infections17202022-06-06
DREAMM-3
NCT04162210
P3Active, not recruitingMultiple Myeloma3252022-09-12 (+12 mo)
Belimumab
NCT04179032
P2Active, not recruitingSystemic Lupus Erythematosus252023-01-16 (-2 mo)
DREAMM 7
NCT04246047
P3Active, not recruitingMultiple Myeloma4942023-10-02 (+9 mo)
DREAMM 8
NCT04484623
P3Active, not recruitingMultiple Myeloma3022024-01-29 (+20 mo)
DREAMM 7
NCT06868654
P3Active, not recruitingMultiple Myeloma722024-04-03
DREAMM 7
NCT06868667
P3Active, not recruitingMultiple Myeloma242024-04-03
DREAMM 8
NCT06956170
P3Active, not recruitingMultiple Myeloma212024-05-27
ZEST
NCT04915755
P3Active, not recruitingNeoplasms, Breast402024-06-28 (-7 mo)
Belantamab mafodotin
NCT07150104
P1/2Active, not recruitingMultiple Myeloma142025-04-17
Belantamab mafodotin
NCT07217184
P1/2Active, not recruitingMultiple Myeloma302025-04-17
DREAMM 5
NCT04126200
P1/2Active, not recruitingMultiple Myeloma2082025-04-17 (-13 mo)
Belantamab mafodotin
NCT07084896
P1/2Active, not recruitingMultiple Myeloma1062025-04-17
Belantamab mafodotin
NCT07217119
P1/2Active, not recruitingMultiple Myeloma252025-04-17
Belantamab mafodotin
NCT07150091
P1/2Active, not recruitingMultiple Myeloma202025-04-17
COSTAR Lung
NCT04655976
P2/3Active, not recruitingLung Cancer, Non-Small Cell7582025-06-05 (+9 mo)
PED-HZ/su
NCT04006808
P1/2RecruitingHerpes Zoster1842026-05-01 (+24 mo)
SYLVER
NCT06710847
P1/2Active, not recruitingNeoplasms, Colorectal; Solid Tumor142026-06-22 (-8 mo)
Dostarlimab
NCT06472076
P3Active, not recruitingLung Cancer, Non-Small Cell882026-06-30 (-27 mo)
GSK4524101
NCT06077877
P1/2Active, not recruitingNeoplasms422026-06-30 (+12 mo)
GSK5784283
NCT06748053
P2Active, not recruitingAsthma3072026-07-14
RSVPreF3 OA vaccine
NCT07220109
P3Active, not recruitingRespiratory Syncytial Virus Infections7502026-07-20
Candidate varicella vaccine
NCT06855160
P3RecruitingChickenpox9112026-09-10
Dostarlimab
NCT06062420
P2Active, not recruitingNeoplasms, Head and Neck3162026-09-10 (+12 mo)
OCEAN
NCT05263934
P3Active, not recruitingEosinophilic Granulomatosis With Polyangiitis1632026-09-29 (+12 mo)
RSV OA=ADJ=012
NCT06534892
P3Active, not recruitingRespiratory Syncytial Virus Infections102122026-09-30
LLSAT
NCT04167358
P3Active, not recruitingCholestasis2422026-09-30 (+27 mo)
Cobolimab
NCT06521567
P1/2Active, not recruitingMelanoma; Hodgkin Lymphoma832026-10-13 (-21 mo)
Pembrolizumab
NCT05565378
P2Active, not recruitingLung Cancer, Non-Small Cell3512026-10-26 (+24 mo)
AZUR-1
NCT05723562
P2Active, not recruitingNeoplasms, Rectal1542026-11-02 (+11 mo)
Investigational varicella vaccine
NCT06693895
P3RecruitingChickenpox7502026-11-23 (+4 mo)
dTpa
NCT07596199
P3Active, not recruitingDiphtheria-Tetanus-acellular Pertussis Vaccines1022026-11-23
AZUR-4
NCT06567782
P2RecruitingNeoplasms, Colon1202026-11-23 (-21 mo)
Momelotinib
NCT03441113
P2Active, not recruitingPrimary Myelofibrosis2372026-12-11 (+78 mo)
Investigational varicella vaccine
NCT06806137
P3RecruitingChickenpox6002026-12-14 (+1 mo)
RUBY-J
NCT06317311
P2Active, not recruitingCarcinoma412026-12-14 (+5 mo)
Investigational varicella vaccine_Lot 1
NCT06740630
P3RecruitingChickenpox18402026-12-25
Niraparib
NCT04641247
P2RecruitingOvarian Neoplasms; Breast Neoplasms372026-12-28 (+13 mo)
HFA-152a
NCT07645248
P3RecruitingAsthma1102026-12-28
Adjuvanted RSVPreF3 vaccine
NCT07092865
P2Active, not recruitingRespiratory Syncytial Virus Infections1682027-01-12
FF/UMEC/VI
NCT05757102
P3Active, not recruitingAsthma1382027-01-26 (+28 mo)
GLIDE
NCT07671001
P3RecruitingAsthma342027-03-01
BALANCE
NCT07519395
P2RecruitingIrritable Bowel Syndrome4202027-03-09
MenABCWY vaccine
NCT05087056
P2Active, not recruitingMeningitis, Meningococcal3052027-03-10 (+9 mo)
ODYSSEY
NCT06517875
P2RecruitingPrimary Myelofibrosis; Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis682027-03-16 (+7 mo)
B-Focus
NCT06497504
P2Active, not recruitingHepatitis B1532027-04-22 (+3 mo)
RTS,S/AS01E vaccine
NCT07036159
P2RecruitingMalaria2382027-04-23
GSK3862995B
NCT07201051
P2RecruitingBronchiectasis3632027-05-04 (+2 mo)
Tafenoquine
NCT06666491
P3RecruitingMalaria, Vivax3242027-05-14 (+13 mo)
Candidate UTI vaccine low dose formulation 1
NCT06702449
P1/2RecruitingUrinary Tract Infections4482027-05-31 (-2 mo)
B-UNITED
NCT06537414
P2Active, not recruitingChronic Hepatitis B Virus Infection; Hepatitis B2832027-05-31 (-7 mo)
Mo-Rez
NCT06796907
P1/2RecruitingTumours, Gynecological3052027-06-21 (+5 mo)
mRNA Seasonal Flu vaccine
NCT07851246
P3RecruitingInfluenza, Human30002027-07-09
MIDAS
NCT06847867
P2RecruitingMyelodysplastic Syndromes802027-07-14 (+3 mo)
HZ/su vaccine
NCT05371080
P3Active, not recruitingHerpes Zoster30382027-08-23
CALM-2
NCT07650084
P3RecruitingRefractory Chronic Cough752027-08-27
GSK3772701 600 mg
NCT07545681
P2RecruitingMalaria, Falciparum702027-10-08
China AZUR-1
NCT06640049
P2Active, not recruitingNeoplasms, Rectal232027-10-24 (-14 mo)
GSK5458514
NCT06990880
P1/2RecruitingNeoplasms, Prostate852027-10-26
DESTINY
NCT05334368
P3Active, not recruitingHypereosinophilic Syndrome1102027-10-29 (+30 mo)
Ris-Rez
NCT07602777
P1/2RecruitingSarcoma642027-11-05
Risvutatug rezetecan (Ris-Rez)
NCT07099898
P3RecruitingNeoplasms, Lung4202027-11-05 (+14 mo)
STARLIGHT
NCT06613698
P2RecruitingLiver Diseases, Alcoholic3502027-11-26 (+12 mo)
Velzatinib
NCT07689201
P2RecruitingGastrointestinal Neoplasms242027-11-29
Depemokimab
NCT06979323
P3RecruitingAsthma1502028-01-05 (-1 mo)
MMRVNS
NCT07406360
P3RecruitingMeasles; Measles-Mumps-Rubella+Chickenpox Vaccine12092028-02-28
Mocertatug rezetecan
NCT07286331
P3RecruitingNeoplasms, Endometrial6002028-02-29
GSK5471713
NCT07332455
P1/2RecruitingNeoplasms, Prostate542028-03-24
ZENITH-2
NCT07221188
P3RecruitingNon-alcoholic Fatty Liver Disease12502028-03-24
ZENITH-1
NCT07221227
P3RecruitingNon-alcoholic Fatty Liver Disease12002028-03-29
Low dose of iNTS-TCV
NCT07286370
P2RecruitingSalmonella Infections5372028-04-27
IDRX-42
NCT07218926
P3RecruitingGastrointestinal Neoplasms4502028-05-30 (+1 mo)
mRNA Seasonal Flu vaccine
NCT07805707
P3RecruitingInfluenza, Human540002028-06-09
MMRVNS 20-002
NCT07742644
P3Not yet recruitingMeasles; Mumps18602028-06-27
JADE
NCT06256588
P3RecruitingNeoplasms, Head and Neck8642028-06-30
Efimosfermin
NCT06920043
P2RecruitingMetabolic Dysfunction-Associated Steatohepatitis; Non-alcoholic Fatty Liver Disease422028-07-03 (+8 mo)
DynaMMic-1
NCT05714839
P1/2RecruitingMultiple Myeloma1232028-08-03 (+13 mo)
ALLSTAR
NCT07791043
P2RecruitingLiver Diseases, Alcoholic2742028-08-11
GSK4527226
NCT07105709
P2RecruitingAlzheimer's Disease2202028-09-15
GSK5460025
NCT07213609
P1/2RecruitingNeoplasms, Colorectal; Neoplasms472028-09-28
H06_04TP
NCT07320716
P2RecruitingDiarrhoea1792028-10-16
Linerixibat
NCT07860710
P3Not yet recruitingPruritus402028-10-23
ATLAS
NCT07569081
P2/3Not yet recruitingVEXAS Syndrome1362028-12-06
ENDURA-2
NCT06961214
P3RecruitingPulmonary Disease, Chronic Obstructive9612028-12-13 (-8 mo)
ENDURA-1
NCT06959095
P3RecruitingPulmonary Disease, Chronic Obstructive9812028-12-13 (-8 mo)
Risvutatug Rezetecan
NCT06885034
P1/2RecruitingGastrointestinal Neoplasms3462029-01-09 (+25 mo)
B-Sure
NCT04954859
P2Active, not recruitingHepatitis B3662029-01-24 (+78 mo)
GSK5784283
NCT07780643
P3RecruitingAsthma5142029-02-15
DREAMM-16
NCT07614360
P2Not yet recruitingMultiple Myeloma1502029-02-28
PERSISTCRSwNP1
NCT07782970
P3RecruitingNasal Polyps2182029-03-06
PERSISTCRSwNP2
NCT07782957
P3RecruitingNasal Polyps2182029-03-06
ALARMONY
NCT07915791
P2RecruitingPulmonary Disease, Chronic Obstructive2792029-03-07
Dostarlimab
NCT05855200
P3RecruitingColonic Neoplasms; Neoplasms, Colon8922029-03-19 (+3 mo)
VIGILANT
NCT07177339
P3RecruitingPulmonary Disease, Chronic Obstructive11962029-04-02 (-7 mo)
RSV/hMPV_V low dose vaccine
NCT07628049
P1/2RecruitingRespiratory Syncytial Virus Infections+Metapneumovirus14562029-04-05
Adjuvanted RZV vaccine
NCT07712380
P2Not yet recruitingCardiovascular Disease4502029-05-02
GSK5784283
NCT07782996
P3RecruitingAsthma3702029-05-04
Risvutatug rezetecan
NCT07602855
P1/2RecruitingNeoplasms, Lung1842029-06-22
GSK5784283
NCT07780656
P3RecruitingPulmonary Disease, Chronic Obstructive6242029-07-20
GSK5784283
NCT07780669
P3RecruitingPulmonary Disease, Chronic Obstructive6242029-07-20
Mocertatug rezetecan
NCT07684599
P3RecruitingNeoplasms, Endometrial6102029-07-23
BEconneCTD-ILD
NCT06572384
P3RecruitingLung Diseases, Interstitial4402029-08-30 (+10 mo)
BLISSc-ILD
NCT05878717
P2/3RecruitingSystemic Sclerosis Associated Interstitial Lung Disease; Scleroderma, Systemic3002029-08-30 (+34 mo)
Mocertatug rezetecan
NCT07694427
P3RecruitingOvarian Neoplasms7202029-09-06
Risvutatug rezetecan (Ris-Rez)
NCT07802704
P3RecruitingNeoplasms, Prostate6842029-12-05
GSK5926371
NCT07607925
P1/2RecruitingLymphoma, Non-Hodgkin492030-01-10
DuraSTAR
NCT07740720
P3Not yet recruitingNeoplasms, Rectal1002030-03-13
Dostarlimab
NCT07108270
P2RecruitingNeoplasms, Endometrial302030-03-31
Mocertatug rezetecan (Mo-Rez)
NCT07684612
P3RecruitingOvarian Neoplasms6902030-05-21
Mocertatug rezetecan
NCT07286266
P3RecruitingOvarian Neoplasms4502030-07-22
Belantamab mafodotin
NCT07227311
P2RecruitingMultiple Myeloma2002030-08-30 (+2 mo)
MODIFY
NCT07456033
P3RecruitingAsthma4562030-09-23
Belimumab
NCT06716606
P3RecruitingConnective Tissue Diseases5142030-09-27 (+27 mo)
NEBULA-2
NCT07704892
P3RecruitingMetabolic Dysfunction-associated Steatohepatitis3802030-10-16
SAPPHIRE
NCT07860450
P3Not yet recruitingEndometrial Carcinoma; Neoplasms, Endometrial3782030-11-05
Velzatinib
NCT07843641
P2Not yet recruitingGastrointestinal Neoplasms722031-01-31
DREAMM-10
NCT06679101
P3RecruitingMultiple Myeloma; Newly Diagnosed Multiple Myeloma5202031-04-28 (-8 mo)
Velzatinib
NCT07585266
P3RecruitingGastrointestinal Stromal Neoplasms8002032-08-30
RZV vaccine
NCT07872046
P3Not yet recruitingCardiovascular Disease163902032-11-25
ALANIS
NCT07224672
P2RecruitingAmyloidosis602033-01-12 (+68 mo)
NEBULA-1
NCT07701993
P3RecruitingMetabolic Dysfunction-associated Steatohepatitis17402033-06-23